Income Statement SCL Science Inc.

Stocks

A246960

KR7246960009

Pharmaceuticals

End-of-day quote Korea S.E. 2026-10-02			5-day change	1st Jan Change
2,620.00 ^KRW	0.00%		-3.68%	+13.91%

08-14	SCL Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

8569816c0e968e1020d57f9ab5fa1._ONXJevK1D0Hg9pCviifnbfj0dbxgDILHCksfPlQSH4.lIwGRIit5UpLwpss2UXJ2s-X5aDI9ENFUmN8Ha03GRmsiyVS2_igf13V4g

Published financial data: SCL SCIENCE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	507M	370M	1.32B	4.74B	22.01B
Other Revenues, Total	-	-10	-10	-	-
Total Revenues	507M	370M	1.32B	4.74B	22.01B
Cost of Goods Sold, Total	324M	301M	1.11B	2.93B	17.81B
Gross Profit	183M	68.41M	208M	1.81B	4.2B
Selling General & Admin Expenses, Total	3.09B	3.04B	2.66B	3.33B	4.73B
Provision for Bad Debts	-	-	-	2.97M	74.48M
R&D Expenses	1.42B	1.34B	1.24B	1.66B	1.88B
Depreciation & Amortization - (IS)	134M	227M	260M	402M	657M
Amortization of Goodwill and Intangible Assets - (IS)	71.7M	72.34M	68.48M	74.27M	255M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	4.72B	4.67B	4.23B	5.47B	7.6B
Operating Income	-4.54B	-4.61B	-4.02B	-3.66B	-3.4B
Interest Expense, Total	-565M	-874M	-731M	-261M	-2.12B
Interest And Investment Income	99.68M	170M	141M	130M	275M
Net Interest Expenses	-465M	-704M	-590M	-131M	-1.84B
Income (Loss) On Equity Invest.	217M	-67.31M	-2.99B	-	-24.06M
Currency Exchange Gains (Loss)	1.74M	-7.42M	-9.53M	9.42M	137K
Other Non Operating Income (Expenses)	-235M	-567M	2.86B	50.15M	580M
EBT, Excl. Unusual Items	-5.02B	-5.95B	-4.74B	-3.73B	-4.69B
Gain (Loss) On Sale Of Investments	29.8M	-	-	-	21.3M
Gain (Loss) On Sale Of Assets	-10.38M	22K	-63.87M	40.88M	62.09M
Asset Writedown	-14.21M	-33.34M	-215M	-37.82M	-168M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-5.01B	-5.98B	-5.02B	-3.73B	-4.77B
Income Tax Expense	26.54M	-12.42M	2.08M	682K	-651M
Earnings From Continuing Operations	-5.04B	-5.97B	-5.03B	-3.73B	-4.12B
Net Income to Company	-5.04B	-5.97B	-5.03B	-3.73B	-4.12B
Minority Interest	10.74M	99.15K	-724K	-	185M
Net Income - (IS)	-5.03B	-5.97B	-5.03B	-3.73B	-3.93B
Net Income to Common Incl Extra Items	-5.03B	-5.97B	-5.03B	-3.73B	-3.93B
Net Income to Common Excl. Extra Items	-5.03B	-5.97B	-5.03B	-3.73B	-3.93B
Per Share Items
Net EPS - Basic	-249.26	-282.61	-200.01	-128.35	-120.03
Basic EPS - Continuing Operations	-249.26	-282.61	-200.01	-128.35	-120.03
Basic Weighted Average Shares Outstanding	20.18M	21.13M	25.13M	29.06M	32.78M
Net EPS - Diluted	-249.26	-282.61	-200.01	-128.35	-120.03
Diluted EPS - Continuing Operations	-249.26	-282.61	-200.01	-128.35	-120.03
Diluted Weighted Average Shares Outstanding	20.18M	21.13M	25.13M	29.06M	32.78M
Normalized Basic EPS	-154.93	-176.01	-118.02	-80.27	-83.7
Normalized Diluted EPS	-154.93	-176.01	-118.02	-80.27	-83.7
Supplemental Items
EBITDA	-3.86B	-3.85B	-3.22B	-2.53B	-353M
EBITA	-4.47B	-4.53B	-3.95B	-3.54B	-2.52B
EBIT	-4.54B	-4.61B	-4.02B	-3.66B	-3.4B
EBITDAR	-3.86B	-3.85B	-3.21B	-2.5B	-150M
Effective Tax Rate - (Ratio)	-0.53	0.21	-0.04	-0.02	13.65
Normalized Net Income	-3.13B	-3.72B	-2.97B	-2.33B	-2.74B
Supplemental Operating Expense Items
Marketing Expenses	26.22M	17.49M	3.88M	6.48M	414K
Selling and Marketing Expenses	683M	671M	823M	978M	1.37B
General and Administrative Expenses	13.01M	15.67M	12.85M	15.95M	22.17M
Research And Development Expense From Footnotes	1.42B	1.34B	1.24B	1.66B	1.88B
Net Rental Expense, Total	2.53M	2.4M	7.74M	30.4M	203M
Imputed Operating Lease Interest Expense	1.11M	1.13M	4.45M	10.29M	209M
Imputed Operating Lease Depreciation	1.42M	1.27M	3.29M	20.11M	-5.46M
Stock-Based Comp., SG&A Exp. (Total)	31.96M	123M	74.88M	21.81M	-43.39M
Total Stock-Based Compensation	31.96M	123M	74.88M	21.81M	-43.39M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	1.03B	1.82B	5.05B	937M	4.17B
Short Term Investments	9.4B	3B	4.1B	177M	1.01B
Trading Asset Securities, Total	-	-	-	-	1.04B
Total Cash And Short Term Investments	10.43B	4.82B	9.15B	1.11B	6.22B
Accounts Receivable, Total	81.23M	96.46M	643M	2.11B	9.66B
Other Receivables	146M	162M	407M	338M	3.7B
Notes Receivable	-	-	-	-	250M
Total Receivables	227M	258M	1.05B	2.45B	13.61B
Inventory	149M	306M	265M	597M	1.4B
Prepaid Expenses	22.3M	21.36M	22.5M	32M	47.12M
Other Current Assets, Total	31.61M	62.89M	58.47M	1.26B	2.33B
Total Current Assets	10.86B	5.47B	10.55B	5.45B	23.61B
Gross Property Plant And Equipment	10.8B	14.26B	15.89B	10.03B	25.43B
Accumulated Depreciation	-337M	-383M	-120M	-245M	-1.35B
Net Property Plant And Equipment	10.46B	13.88B	15.77B	9.79B	24.08B
Long-term Investments	9.79B	10.37B	2.32B	3.95B	5.25B
Goodwill	-	-	-	-	15.61B
Other Intangibles, Total	214M	714M	153M	2.44B	8.99B
Accounts Receivable Long-Term	20	-	-	-	-
Loans Receivable Long-Term	320M	-	-	-	-
Deferred Charges Long-Term	-	-	1.01B	2.25B	1.61B
Other Long-Term Assets, Total	245M	382M	350M	179M	767M
Total Assets	31.88B	30.81B	30.16B	24.06B	79.92B
Liabilities
Accounts Payable, Total	2.63M	18.45M	675K	1.54M	1.8B
Accrued Expenses, Total	98.03M	87.4M	92.94M	121M	435M
Short-term Borrowings	-	-	348M	401M	-
Current Portion of Long-Term Debt	243M	1.77B	1.12B	381M	10.33B
Current Portion of Leases	122M	107M	158M	212M	2.06B
Current Income Taxes Payable	-	-	321K	-	-
Unearned Revenue Current, Total	45.83M	-	-	-	-
Other Current Liabilities	147M	479M	1.63B	2.27B	6.52B
Total Current Liabilities	657M	2.47B	3.36B	3.38B	21.14B
Long-Term Debt	17.05B	10.34B	6.27B	3.05B	12.16B
Long-Term Leases	128M	22.43M	194M	215M	4.2B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	892M	570M	960M	1.49B	4.41B
Deferred Tax Liability Non Current	-	784M	365M	291M	690M
Other Non Current Liabilities	2.96B	3.46B	109M	37.31M	10.23B
Total Liabilities	21.68B	17.65B	11.26B	8.46B	52.83B
Preferred Stock Redeemable	-	-	-	75.22M	3.59B
Total Preferred Equity	-	-	-	75.22M	3.59B
Common Stock, Total	2.52B	2.8B	3.62B	3.64B	17.01B
Additional Paid In Capital	32.65B	38.49B	47.37B	47.78B	47.24B
Retained Earnings	-26.01B	-32.16B	-35.7B	-39.62B	-43.45B
Treasury Stock	-	-	-	-	-19.8M
Comprehensive Income and Other	918M	3.92B	3.62B	3.72B	3.67B
Total Common Equity	10.08B	13.05B	18.9B	15.52B	24.45B
Minority Interest	123M	124M	-	-	-951M
Total Equity	10.2B	13.17B	18.9B	15.59B	27.09B
Total Liabilities And Equity	31.88B	30.81B	30.16B	24.06B	79.92B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.18M	22.8M	28.95M	29.13M	34.01M
ECS Total Common Shares Outstanding	20.18M	22.8M	28.95M	29.13M	34.01M
Book Value / Share	499.53	572.11	653.01	532.63	718.77
Tangible Book Value	9.86B	12.33B	18.75B	13.08B	-157M
Tangible Book Value Per Share	488.92	540.81	647.71	448.81	-4.6
Total Debt	17.54B	12.24B	8.09B	4.26B	28.76B
Net Debt	7.11B	7.42B	-1.05B	3.15B	22.53B
Debt Equivalent Oper. Leases	20.22M	19.19M	61.9M	243M	1.62B
Minority Interest, Total (Incl. Fin. Div)	123M	124M	-	-	-951M
Equity Method Investments, Total	6.17B	6.03B	-	-	1.15B
Inventories - Raw Materials, Total	59.34M	130M	187M	382M	1.08B
Inventories - Work In Process, Total	12.46M	36.81M	11.14M	127M	154M
Inventories - Finished Goods, Total	95.58M	147M	90.6M	88.68M	166M
Inventories - Others	-250	-320	340	40	20
Land - (BS)	4.76B	6.61B	7.26B	3.19B	6.29B
Buildings, Total	3.87B	5.66B	6.6B	4.66B	9.98B
Machinery, Total	452M	602M	460M	577M	1.12B
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	2.97M	130M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	-5.03B	-5.97B	-5.03B	-3.73B	-3.93B
Depreciation & Amortization - CF	601M	684M	732M	1.01B	2.17B
Amortization of Goodwill and Intangible Assets - (CF)	71.7M	72.34M	68.48M	119M	879M
Depreciation & Amortization, Total	673M	756M	800M	1.13B	3.05B
(Gain) Loss From Sale Of Asset	-231K	-	2.03B	-40.88M	-62.09M
(Gain) Loss on Sale of Investments - (CF)	123M	33.54M	1.13B	37.82M	147M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-345M	67.09M	106M	-	24.06M
Stock-Based Compensation (CF)	31.96M	129M	75.91M	25.96M	-43.1M
Provision and Write-off of Bad Debts	-	-	-	2.97M	74.48M
Other Operating Activities, Total	824M	1.21B	-2.29B	235M	745M
Change In Accounts Receivable	-14.63M	-4.08M	-497M	-1.45B	-5.37B
Change In Inventories	-12.48M	-146M	25.63M	-309M	-52.39M
Change In Accounts Payable	-198M	260M	-171M	336M	2.17B
Change In Income Taxes	-8.7M	-31.78M	-	-	-
Change in Other Net Operating Assets	-27.18M	-409M	1B	-2.2B	2.23B
Cash from Operations	-3.98B	-4.1B	-2.82B	-5.96B	-1.03B
Capital Expenditure	-6.34B	-340M	-2.37B	-586M	-879M
Sale of Property, Plant, and Equipment	-	-	-	5.93B	145M
Cash Acquisitions	-	-	-	-	-2.56B
Divestitures	-	-	6.12B	-	-
Sale (Purchase) of Intangible assets	-	-550M	-521M	-1.97B	-2.73B
Investment in Marketable and Equity Securities, Total	-8.44B	5.6B	-1.63B	2.34B	-3.15B
Net (Increase) Decrease in Loans Originated / Sold - Investing	260M	320M	-	-	-
Other Investing Activities, Total	8.53M	7.42M	-56.82M	-70.87M	-181M
Cash from Investing	-14.51B	5.04B	1.53B	5.65B	-9.36B
Short Term Debt Issued, Total	-	-	-	-	7.52B
Long-Term Debt Issued, Total	11.5B	-	1.6B	-	14B
Total Debt Issued	11.5B	-	1.6B	-	21.52B
Short Term Debt Repaid, Total	-	-243M	-	-	-4.07B
Long-Term Debt Repaid, Total	-103M	-132M	-8.08B	-3.79B	-4.98B
Total Debt Repaid	-103M	-374M	-8.08B	-3.79B	-9.05B
Issuance of Common Stock	30M	235M	10.99B	-	-
Repurchase of Common Stock	-	-	-	-	-19.8M
Issuance of Preferred Stock	7.5B	-	-	-	300M
Other Financing Activities, Total	18M	-	-10	-18M	878M
Cash from Financing	18.94B	-140M	4.51B	-3.81B	13.63B
Foreign Exchange Rate Adjustments	3.37M	-2.66M	807K	12.55M	-1.28M
Net Change in Cash	455M	791M	3.22B	-4.11B	3.24B
Supplemental Items
Cash Interest Paid	155M	240M	333M	265M	1.16B
Cash Income Tax Paid (Refund)	-15.25M	-10.99M	-6M	649K	8.29M
Levered Free Cash Flow	-8.52B	-3.36B	-4.68B	-6.09B	-10.74B
Unlevered Free Cash Flow	-8.17B	-2.82B	-4.22B	-5.93B	-9.42B
Change In Net Working Capital	-307M	-73.05M	-307M	2.24B	6.69B
Net Debt Issued / Repaid	11.4B	-374M	-6.48B	-3.79B	12.47B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	-11.52	-9.18	-8.24	-8.44	-4.08
Return on Total Capital	-12.95	-10.83	-9.58	-9.77	-5.61
Return On Equity %	-43.4	-51.11	-31.34	-21.63	-19.3
Return on Common Equity	-43.69	-51.65	-31.47	-21.67	-19.69
Margin Analysis
Gross Profit Margin %	36.17	18.5	15.76	38.18	19.09
SG&A Margin	609.59	821.21	201.35	70.22	21.49
EBITDA Margin %	-761.84	-1.04K	-243.31	-53.39	-1.6
EBITA Margin %	-880.39	-1.23K	-298.67	-74.76	-11.45
EBIT Margin %	-894.52	-1.25K	-303.85	-77.28	-15.44
Income From Continuing Operations Margin %	-993.51	-1.62K	-380.12	-78.74	-18.72
Net Income Margin %	-991.39	-1.61K	-380.17	-78.74	-17.87
Net Avail. For Common Margin %	-991.39	-1.61K	-380.17	-78.74	-17.87
Normalized Net Income Margin	-616.2	-1.01K	-224.34	-49.25	-12.46
Levered Free Cash Flow Margin	-1.68K	-909.33	-354.05	-128.63	-48.81
Unlevered Free Cash Flow Margin	-1.61K	-761.58	-319.51	-125.19	-42.8
Asset Turnover
Asset Turnover	0.02	0.01	0.04	0.17	0.42
Fixed Assets Turnover	0.07	0.03	0.09	0.37	1.3
Receivables Turnover (Average Receivables)	4.85	4.16	3.58	3.44	3.74
Inventory Turnover (Average Inventory)	2.12	1.33	3.9	6.79	17.86
Short Term Liquidity
Current Ratio	16.52	2.22	3.14	1.61	1.12
Quick Ratio	16.21	2.06	3.04	1.05	0.93
Operating Cash Flow to Current Liabilities	-6.06	-1.66	-0.84	-1.76	-0.05
Days Sales Outstanding (Average Receivables)	75.33	87.7	102.09	106.54	97.65
Days Outstanding Inventory (Average Inventory)	171.82	275.06	93.48	53.87	20.43
Average Days Payable Outstanding	4.21	8.4	3.25	0.12	17.63
Cash Conversion Cycle (Average Days)	242.94	354.36	192.31	160.28	100.46
Long Term Solvency
Total Debt/Equity	171.91	92.98	42.82	27.31	106.14
Total Debt / Total Capital	63.22	48.18	29.98	21.45	51.49
LT Debt/Equity	168.34	78.7	34.21	20.94	60.42
Long-Term Debt / Total Capital	61.91	40.78	23.95	16.45	29.31
Total Liabilities / Total Assets	68	57.26	37.32	35.19	66.1
EBIT / Interest Expense	-8.04	-5.27	-5.5	-14.01	-1.6
EBITDA / Interest Expense	-6.84	-4.4	-4.4	-9.68	-0.17
(EBITDA - Capex) / Interest Expense	-18.08	-4.79	-7.65	-11.92	-0.58
Total Debt / EBITDA	-4.54	-3.18	-2.52	-1.68	-81.52
Net Debt / EBITDA	-1.84	-1.93	0.33	-1.24	-63.87
Total Debt / (EBITDA - Capex)	-1.72	-2.92	-1.45	-1.37	-23.35
Net Debt / (EBITDA - Capex)	-0.7	-1.77	0.19	-1.01	-18.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-14.91	-27.11	257.54	258.3	364.64
Gross Profit, 1 Yr. Growth %	-45.92	-62.72	204.66	767.86	132.26
EBITDA, 1 Yr. Growth %	22.49	-0.42	-16.42	-21.38	-86.05
EBITA, 1 Yr. Growth %	22.91	1.49	-12.88	-10.31	-28.87
EBIT, 1 Yr. Growth %	22.73	1.48	-12.77	-8.87	-7.18
Earnings From Cont. Operations, 1 Yr. Growth %	66	18.49	-15.85	-25.78	10.44
Net Income, 1 Yr. Growth %	65.03	18.74	-15.83	-25.79	5.47
Normalized Net Income, 1 Yr. Growth %	46.41	18.98	-20.25	-21.35	17.6
Diluted EPS Before Extra, 1 Yr. Growth %	65.03	13.38	-29.23	-35.83	-6.49
Accounts Receivable, 1 Yr. Growth %	-36.62	18.75	566.67	228.84	356.92
Inventory, 1 Yr. Growth %	-4.82	105.54	-13.31	125.43	133.93
Net Property, Plant and Equip., 1 Yr. Growth %	123.49	32.71	13.63	-37.95	145.99
Total Assets, 1 Yr. Growth %	83.75	-3.35	-2.13	-20.23	232.22
Tangible Book Value, 1 Yr. Growth %	-22.87	25	52.05	-30.26	-101.2
Common Equity, 1 Yr. Growth %	-22.13	29.43	44.9	-17.91	57.56
Cash From Operations, 1 Yr. Growth %	38.72	3.04	-31.31	111.35	-82.73
Capital Expenditures, 1 Yr. Growth %	248.78	-94.64	598.31	-75.3	49.85
Levered Free Cash Flow, 1 Yr. Growth %	125.38	-60.54	42.88	29.16	76.32
Unlevered Free Cash Flow, 1 Yr. Growth %	118.04	-65.52	54.74	39.17	58.85
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-14.43	-21.25	61.44	257.92	308.02
Gross Profit, 2 Yr. CAGR %	-29.05	-55.1	6.57	414.2	348.97
EBITDA, 2 Yr. CAGR %	5.41	10.45	-8.77	-18.94	-66.88
EBITA, 2 Yr. CAGR %	7.82	11.69	-5.97	-11.61	-20.13
EBIT, 2 Yr. CAGR %	7.86	11.6	-5.91	-10.84	-8.03
Earnings From Cont. Operations, 2 Yr. CAGR %	12.4	40.25	-0.14	-20.97	-9.46
Net Income, 2 Yr. CAGR %	12.28	39.99	-0.03	-20.97	-11.53
Normalized Net Income, 2 Yr. CAGR %	11.98	31.99	-2.59	-20.8	-3.83
Diluted EPS Before Extra, 2 Yr. CAGR %	11.62	36.79	-10.42	-32.61	-22.53
Accounts Receivable, 2 Yr. CAGR %	-28.9	-13.24	181.37	368.22	287.63
Inventory, 2 Yr. CAGR %	-6.45	39.87	33.48	39.79	129.64
Net Property, Plant and Equip., 2 Yr. CAGR %	83.65	72.22	22.8	-16.03	23.55
Total Assets, 2 Yr. CAGR %	36.02	33.26	-2.74	-11.64	62.79
Tangible Book Value, 2 Yr. CAGR %	-18.64	-1.81	37.86	2.97	-90.86
Common Equity, 2 Yr. CAGR %	-18.25	0.4	36.95	9.06	13.73
Cash From Operations, 2 Yr. CAGR %	10.47	19.56	-15.87	20.49	-39.58
Capital Expenditures, 2 Yr. CAGR %	371.44	-56.76	-38.82	31.33	-39.16
Levered Free Cash Flow, 2 Yr. CAGR %	98.37	-5.69	-25.88	36.38	50.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	95.04	-13.29	-28.08	47.39	48.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.32	-18.88	30.4	110.58	290.45
Gross Profit, 3 Yr. CAGR %	-5.64	-42.75	-15	114.41	294.53
EBITDA, 3 Yr. CAGR %	19.47	3.43	0.65	-13.18	-54.91
EBITA, 3 Yr. CAGR %	20.63	5.67	2.81	-7.44	-17.78
EBIT, 3 Yr. CAGR %	20.61	5.69	2.8	-6.91	-9.64
Earnings From Cont. Operations, 3 Yr. CAGR %	25.1	14.4	18.29	-9.55	-11.64
Net Income, 3 Yr. CAGR %	25.01	14.4	18.15	-9.48	-12.99
Normalized Net Income, 3 Yr. CAGR %	24.56	14.27	11.58	-9.29	-9.65
Diluted EPS Before Extra, 3 Yr. CAGR %	16.83	12.2	9.81	-19.85	-24.83
Accounts Receivable, 3 Yr. CAGR %	-22.94	-15.64	71.2	196.38	364.42
Inventory, 3 Yr. CAGR %	-7.55	21.62	19.25	58.96	65.97
Net Property, Plant and Equip., 3 Yr. CAGR %	54.28	64.8	49.93	-2.19	20.15
Total Assets, 3 Yr. CAGR %	41.82	21.38	20.23	-8.96	37.4
Tangible Book Value, 3 Yr. CAGR %	1.67	-6.12	13.6	9.85	-76.67
Common Equity, 3 Yr. CAGR %	1.93	-4.72	13.46	15.47	23.29
Cash From Operations, 3 Yr. CAGR %	22.27	7.94	-0.61	14.37	-36.94
Capital Expenditures, 3 Yr. CAGR %	510.81	6.01	9.3	-54.78	37.23
Levered Free Cash Flow, 3 Yr. CAGR %	82.87	15.8	7.38	-10.57	48.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	81.03	9.46	4.09	-10.12	51.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	38.22	12.77	20.88	46.89	105.8
Gross Profit, 5 Yr. CAGR %	48.2	40.38	-0.93	37.76	65.4
EBITDA, 5 Yr. CAGR %	21.06	11.86	7.25	-6.18	-35.48
EBITA, 5 Yr. CAGR %	21.96	12.53	9.19	-1.61	-7.06
EBIT, 5 Yr. CAGR %	20.33	11.57	9.21	-1.26	-1.67
Earnings From Cont. Operations, 5 Yr. CAGR %	45.31	14.67	14.32	-1.33	6.29
Net Income, 5 Yr. CAGR %	45.25	14.67	14.32	-1.33	5.24
Normalized Net Income, 5 Yr. CAGR %	44.85	17.44	12.89	-1.32	5.14
Diluted EPS Before Extra, 5 Yr. CAGR %	29.67	7.68	5.05	-8.5	-4.49
Accounts Receivable, 5 Yr. CAGR %	78.72	15.13	29.37	67.44	137.39
Inventory, 5 Yr. CAGR %	16.25	15.04	7.08	28.58	54.99
Net Property, Plant and Equip., 5 Yr. CAGR %	25.63	35.04	40.82	25.84	38.76
Total Assets, 5 Yr. CAGR %	35.3	48.94	21.96	6.9	35.73
Tangible Book Value, 5 Yr. CAGR %	10.68	32.87	14.84	-2.58	-58.55
Common Equity, 5 Yr. CAGR %	10.66	33.33	14.71	0.57	13.57
Cash From Operations, 5 Yr. CAGR %	28.83	12.68	5.29	12.79	-18.55
Capital Expenditures, 5 Yr. CAGR %	47.66	40.31	143.33	15.49	-13.54
Levered Free Cash Flow, 5 Yr. CAGR %	12.97	17.27	27.43	22.99	23.23
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.77	13.22	25.14	22.53	20.25